STOCKHOLDERS' EQUITY (Details - Stock warrants activity) - Common Stock Warrants [Member] - USD ($) |
3 Months Ended |
|---|---|
Mar. 31, 2025 | |
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |
| Shares outstanding, Beginning | 200,332 |
| Weighted average exercise price outstanding, Beginning | $ 91.58 |
| Shares, Granted | 11,592,576 |
| Weighted average exercise price, Granted | $ 1.04 |
| Shares, Exercised | (1,408,928) |
| Weighted average exercise price, Exercised | $ 0.00002 |
| Shares outstanding, Ending | 10,383,980 |
| Weighted average exercise price outstanding, Ending | $ 2.88 |
| Weighted average remaining life in years, Outstanding | 4 years 10 months 6 days |
| Intrinsic value, Outstanding | $ 3,871,236 |
| Shares, Exercisable | 10,383,980 |
| Weighted average exercise price, Exercisable | $ 2.88 |
| Weighted average remaining life in years, Exercisable | 4 years 10 months 6 days |
| Intrinsic value, Exercisable | $ 3,871,236 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|